taking semaglutide but not losing weight Why am I on (Ozempic/Wegovy)? taking semaglutide and not losing

Response assessed at session 4 and session 8

The very first lawsuit was filed on August 2, 2023, against Ozempic over gastrointestinal injuries caused by the medication

Semaglutide is also FDA-approved under the brand name Wegovy for chronic weight management in eligible patients

GLP-1 receptor agonists are incretin-based therapies that: Enhance glucose-dependent insulin secretion Suppress glucagon release Slow gastric emptying Promote satiety and weight loss Common medications include: Semaglutide Tirzepatide Dulaglutide Liraglutide Their ability to delay gastric emptying is central to both their therapeutic benefits and perioperative risks